Clinical trial
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
NCT00003035 · Georgetown University, Other · Completed
Key facts
| NCT number | NCT00003035 |
|---|---|
| Title | Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer |
| Official title | A Pilot Trial Comparing Doxorubicin and Paclitaxel Induced Apoptosis in Locally Advanced Breast Cancer |
| Lead sponsor | Georgetown University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, doxorubicin hydrochloride, paclitaxel, tamoxifen citrate, surgical procedure, radiation therapy |
| Enrollment | 40 |
| Start date | Mar 1, 1997 |
| Primary completion | Jun 1, 2001 |
| Completion | Jun 1, 2001 |
| First posted | Feb 19, 2004 |
| Last update posted | Mar 24, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: